Safety of Percutaneous Cryoablation in Patients with Painful Bone and Soft Tissue Tumors: A Single Center Prospective Study (SCIRO-1502)
Phase 1
- Conditions
- Painful bone and soft tissue tumor
- Registration Number
- JPRN-UMIN000019077
- Lead Sponsor
- Okayama University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Vital organ and/or vessel on the needle route. 2) Patient has the following comorbidities. a) Heart failure (NYHA >= III) b) Active infection except for virus hepatitis 3) Body temperature of 38 degree or more. 4) Target lesion is not able to be evaluated with imagings. 5) Pregnant. 6) Worse bone fracture caused by cryoablation. 7) Worse quality of life caused by cryoablation. 8) Inadequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions. 9) Not eligible determined by the responding physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of adverse events (Time Frame: 1 month post-cryoablation)
- Secondary Outcome Measures
Name Time Method Difference in VAS, efficacy, and imagings 1 month after cryoablation